Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fye

Showing results (161-170 of 196) with videos related to

Pageof 20
Sort By:
Circulation|September 26, 2001
Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapyD F Moore, L T Scott, M T Gladwin, et al.
Controlled Clinical Trials|December 4, 2003
The role of the pharmacy coordinating center in the DIG trialCarol L Fye, William H Gagne, Dennis W Raisch, et al.
Archives of Internal Medicine|September 11, 1995
Response to a second single antihypertensive agent used as monotherapy for hypertension after failure of the initial drug. Department of Veterans Affairs Cooperative Study Group on Antihypertensive AgentsB J Materson, D J Reda, R A Preston, et al.
World Journal of Hepatology|April 9, 2016
Hepatocellular carcinoma: Review of disease and tumor biomarkersJin Un Kim, Mohamed I F Shariff, Mary M E Crossey, et al.
The American Journal of Cardiology|January 1, 1993
Rationale and design of the Department of Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial (HIT) for secondary prevention of coronary artery disease in men with low high-density lipoprotein cholesterol and desirable low-density lipoprotein cholesterolH B Rubins, S J Robins, M K Iwane, et al.
Viruses|July 27, 2024
The Oncolytic Avian Reovirus p17 Protein Inhibits Invadopodia Formation in Murine Melanoma Cancer Cells by Suppressing the FAK/Src Pathway and the Formation of theTKs5/NCK1 ComplexChao-Yu Hsu, Jyun-Yi Li, En-Ying Yang, et al.
Plos Pathogens|March 25, 2021
The antioxidant response favors Leishmania parasites survival, limits inflammation and reprograms the host cell metabolismMarta Reverte, Remzi Onur Eren, Baijayanti Jha, et al.
Frontiers in Immunology|August 9, 2024
Assessing immune factors in maternal milk and paired infant plasma antibody binding to human rhinovirusesJessica M Vera, Sean J McIlwain, Samantha Fye, et al.
The Journal of Infectious Diseases|July 1, 2015
Association of the Endobiont Double-Stranded RNA Virus LRV1 With Treatment Failure for Human Leishmaniasis Caused by Leishmania braziliensis in Peru and BoliviaVanessa Adaui, Lon-Fye Lye, Natalia S Akopyants, et al.
Molecular and Biochemical Parasitology|August 23, 2016
Low frequency of LRV1 in Leishmania braziliensis strains isolated from typical and atypical lesions in the State of Minas Gerais, BrazilDiego H Macedo, Armando Menezes-Neto, Jeronimo M Rugani, et al.
Pageof 20

Showing results (161-170 of 196) with videos related to

Sort By:
Pageof 20
Circulation|September 26, 2001
Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapyD F Moore, L T Scott, M T Gladwin, et al.
Controlled Clinical Trials|December 4, 2003
The role of the pharmacy coordinating center in the DIG trialCarol L Fye, William H Gagne, Dennis W Raisch, et al.
Archives of Internal Medicine|September 11, 1995
Response to a second single antihypertensive agent used as monotherapy for hypertension after failure of the initial drug. Department of Veterans Affairs Cooperative Study Group on Antihypertensive AgentsB J Materson, D J Reda, R A Preston, et al.
World Journal of Hepatology|April 9, 2016
Hepatocellular carcinoma: Review of disease and tumor biomarkersJin Un Kim, Mohamed I F Shariff, Mary M E Crossey, et al.
The American Journal of Cardiology|January 1, 1993
Rationale and design of the Department of Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial (HIT) for secondary prevention of coronary artery disease in men with low high-density lipoprotein cholesterol and desirable low-density lipoprotein cholesterolH B Rubins, S J Robins, M K Iwane, et al.
Viruses|July 27, 2024
The Oncolytic Avian Reovirus p17 Protein Inhibits Invadopodia Formation in Murine Melanoma Cancer Cells by Suppressing the FAK/Src Pathway and the Formation of theTKs5/NCK1 ComplexChao-Yu Hsu, Jyun-Yi Li, En-Ying Yang, et al.
Plos Pathogens|March 25, 2021
The antioxidant response favors Leishmania parasites survival, limits inflammation and reprograms the host cell metabolismMarta Reverte, Remzi Onur Eren, Baijayanti Jha, et al.
Frontiers in Immunology|August 9, 2024
Assessing immune factors in maternal milk and paired infant plasma antibody binding to human rhinovirusesJessica M Vera, Sean J McIlwain, Samantha Fye, et al.
The Journal of Infectious Diseases|July 1, 2015
Association of the Endobiont Double-Stranded RNA Virus LRV1 With Treatment Failure for Human Leishmaniasis Caused by Leishmania braziliensis in Peru and BoliviaVanessa Adaui, Lon-Fye Lye, Natalia S Akopyants, et al.
Molecular and Biochemical Parasitology|August 23, 2016
Low frequency of LRV1 in Leishmania braziliensis strains isolated from typical and atypical lesions in the State of Minas Gerais, BrazilDiego H Macedo, Armando Menezes-Neto, Jeronimo M Rugani, et al.
Pageof 20